European Markets Mixed on Christmas Eve 2025

European markets ended mixed this Christmas Eve, with Novo Nordisk jumping another 9% after its groundbreaking GLP-1 pill approval. Gold...

24/12/2025

3 views

Novo Nordisk Surges 6% After Historic GLP-1 Pill Approval

The FDA just greenlit the very first GLP-1 pill for obesity — and Novo Nordisk shares jumped 6% in minutes....

23/12/2025

2 views

Eli Lilly just dropped game-changing news: their experimental obesity pill lets patients hold onto most of their hard-earned weight loss...

18/12/2025

3 views

Eli Lilly’s new weight loss pill, orforglipron, promises to transform obesity and diabetes care. But can it deliver without the...

26/08/2025

2 views